NPTX2 mRNA and protein expression levels were previously reported to be significantly higher in colorectal carcinoma (CRC), clear cell renal cell carcinoma (ccRCC), and neuroblastoma than in normal tissue [31,32,37]. This evidence concerns the gene NPTX2 and clear cell renal carcinoma.